Vasoconstrictor Therapy for the Hepatorenal Syndrome
- 31 May 2008
- journal article
- editorial
- Published by Elsevier BV in Gastroenterology
- Vol. 134 (5), 1608-1611
- https://doi.org/10.1053/j.gastro.2008.03.034
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Terlipressin and Albumin vs Albumin in Patients With Cirrhosis and Hepatorenal Syndrome: A Randomized StudyGastroenterology, 2008
- A Randomized, Prospective, Double-Blind, Placebo-Controlled Trial of Terlipressin for Type 1 Hepatorenal SyndromeGastroenterology, 2008
- Comparison of terlipressin and noradrenalin on cerebral perfusion, intracranial pressure and cerebral extracellular concentrations of lactate and pyruvate in patients with acute liver failure in need of inotropic supportJournal of Hepatology, 2007
- Hepatopulmonary syndrome: More than just a matter of tone?Journal of Hepatology, 2006
- MELD score and clinical type predict prognosis in hepatorenal syndrome: Relevance to liver transplantationJournal of Hepatology, 2005
- Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndromeJournal of Hepatology, 2004
- Worsening of cerebral hyperemia by the administration of terlipressin in acute liver failure with severe encephalopathyJournal of Hepatology, 2004
- Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndromeJournal of Hepatology, 1998
- IMPACT OF PRETRANSPLANT RENAL FUNCTION ON SURVIVAL AFTER LIVER TRANSPLANTATIONTransplantation, 1995
- LONG-TERM SURVIVAL AND RENAL FUNCTION FOLLOWING LIVER TRANSPLANTATION IN PATIENTS WITH AND WITHOUT HEPATORENAL SYNDROMETransplantation, 1991